Toxic, abusive and inept culture and leadership that has only gotten worse. - werkgeversreview Director bij BeOne

1,0
28 jan 2022
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Pay is competitive, but becoming less so over time.

Minpunten

Beigene is a vicious, toxic, abusive company that you should avoid at all costs. Good people may get hired and give you false hope but a toxic culture eventually brings out the worst in everybody. The cloud of toxicity that comes from senior leadership cannot be escaped and will permeate not only your work life, but your personal life. It’s a culture of anxiety and 2nd guessing, where things can’t go smoothly because they’re not allowed to go smoothly. Senior leadership will not lead through inspiration, motivation, and support. It will lead through ego, demands, belittling, disrespect, and intimidation. You are not being hired to think. They are laughably bad at leadership. The CEO talks the talk but those a layer or two beneath him fail to live up to what he promises. Communication is a disaster at nearly every level. Upper management’s approach is to never communicate whatsoever and suddenly expect you to have read their mind or to micromanage you. There’s no in between. This holds for every function: biostats, clinops, clin dev… all of them. It stems straight from the CMOs and VPs. Management will contradict itself. You’ll be given opposing instructions by your superiors. End result: no matter what you do, you were wrong. There is no development plan here: you are being hired as a warm body with no guidance or a glorified assistant to some micromanaging, egotistical VP BeiGene will start gaslighting you the minute you arrive. Better to stay away.

Ontdek andere reviews over BeOne

5,0
24 apr 2026
Anonieme werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

BeOne Medicines is building a strong reputation as a global oncology-focused company with a patient-centered approach. They’ve demonstrated the ability to advance innovative therapies across both hematologic malignancies and solid tumors, while also expanding their global footprint in clinical development. Their collaborative culture and emphasis on scientific rigor make them a compelling organization to work with and learn from.

Minpunten

Fast timelines and global expansion may translate into heavy workload and urgency

1,0
21 mei 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Some great people and opportunities to truly learn the CN market

Minpunten

Toxic culture, lack of coherent leadership strategies, unreasonable expectations

1
Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle